Neumora Therapeutics Inc....

NASDAQ: NMRA · Real-Time Price · USD
1.62
0.04 (2.53%)
At close: Aug 15, 2025, 3:59 PM
1.66
2.47%
After-hours: Aug 15, 2025, 07:51 PM EDT

Neumora Therapeutics Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
142.15M 374.04M 240.94M 409.25M
Short-Term Investments
165.43M 79.94M 130.94M n/a
Long-Term Investments
n/a 9.85M 23.51M n/a
Other Long-Term Assets
n/a 1.21M 4.13M 9.65M
Receivables
n/a 939K 919K 200K
Inventory
n/a n/a 50K 125K
Other Current Assets
6.48M n/a 50K 125K
Total Current Assets
314.06M 478.28M 387.95M 415.6M
Property-Plant & Equipment
2.92M 6.86M 10.64M 4.04M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
2.92M 17.92M 38.28M 13.69M
Total Assets
316.97M 496.19M 426.23M 429.3M
Account Payables
3.31M 337K 7.15M 1.64M
Deferred Revenue
n/a n/a 11.54M 19.1M
Short-Term Debt
1.85M n/a n/a n/a
Other Current Liabilities
24.73M 10.15M 10.04M 8.13M
Total Current Liabilities
29.89M 25.11M 23.7M 23.28M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
22K 155K 844.32M 730.24M
Total Long-Term Liabilities
22K 2.01M 849.39M 731.24M
Total Liabilities
29.91M 27.12M 873.08M 754.52M
Total Debt
1.85M 5.23M 8.44M 2.05M
Common Stock
16K 16K 16K 14K
Retained Earnings
-947.22M -703.43M -467.51M -336.61M
Comprehensive Income
62K -76K -774K -729.86M
Shareholders Equity
287.06M 469.08M -446.85M -325.22M
Total Investments
165.43M 89.79M 154.45M n/a